This study was to assess the relation between body dissatisfaction and depressive symptoms among black adolescents 12-13 years old, among overweight/obese group and healthy weight group, separately. The dataset includes body dissatisafaction and depressive symptoms at baseline, and two follow-ups in two years. Data types included are socio-demographic information of adolescents, the obesity prevention intervention group status, body composition, and psychosocial variables: e.g. depressive symptoms and body dissatisfaction.
An institutional-based cross-sectional study was conducted to assess the prevalence of self-reported symptoms of depression, anxiety, and stress during the COVID-19 pandemic among 846 healthcare workers (HCWs) in central Ethiopia. From June 25, 2020, to July 25, 2020, an online survey was administered to collect self-reported data using the Depression, Anxiety, and Stress Scale (DASS-21). Data were cleaned, coded, and analysed using SPSS Version 23. A multivariable logistic regression analysis was done to identify the associated factors for mental health outcomes at a p-value of less than 0.05.
This dataset is the result of a randomized clinical trial to determine the effect of cognitive therapy and selective use of SSRIs on the morbidity and mortality of depressed myocardial infarction patients. Recruitment of participants took place between October 1996 and October 1999 with the trial terminating in 2001. Data were collected for 2481 study participants, 1243 of whom received usual care and 1238 underwent intervention treatment. The dataset includes demographic information, medical characteristics and history, physical examination, current medications, clinical values, and treatment data and outcomes. A total of 38 different files may be combined based on type of data needed.
Data and figures are provided on the effects of fluoxetine, a selective serotin reuptake inhibitor (SSRI) antidepressant, on the gut microbiome and metabolome in a rat model to better understand the effect of this drug on women during gestation and lactation. Throughout pregnancy and lactation, female rats received the SSRI fluoxetine or vehicle. High resolution 16S ribosomal RNA marker gene sequencing and targeted metabolic analysis were used to assess the fecal microbiome and metabolic availability, respectively.